New ECT technique may zap depression without the memory fog
NCT ID NCT04099342
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 30 times
Summary
This study tests a new way to deliver electroconvulsive therapy (ECT) for people with treatment-resistant depression. By placing electrodes on just one side of the head to better target the prefrontal cortex, researchers hope to keep the antidepressant benefits while reducing memory side effects. The study involves 20 adults with major depression who will receive this modified ECT, called FEAST, and be monitored for seizure activity and mood changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT-RESISTANT DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.